Hypericin is an active ingredient in the herbal medicine St. John’s wort. St. John’s wort is used to treat depression and a number of different maladies with variable degrees of effectiveness including cancer, HIV, irritable bowel syndrome, burning mouth syndrome, premenstrual syndrome, seasonal affective disorder, smoking cessation, social phobia, wound healing, dermatitis and psoriasis and is also sold as a dietary supplement. Hypericin may contribute to these activities as well as have photoactive properties with applications in diagnostics and photodynamic therapy. None of these indications have been approved by the United States Food and Drug Administration (USFDA).
Affygility Solutions has an occupational exposure limit (OEL) and control band assignment for this active pharmaceutical ingredient (API). This monograph also contains the acceptable daily exposure (ADE) value.
OEL Fastrac monographs are a cost-effective and convenient way to meet the requirements for PDEs (ADEs) contained in the EMA Guideline on setting health based exposure limits for use in risk identification in the manufacture of different medicinal products in shared facilities (EMA/CHMP/CVMP/SWP/169430/2012), and to obtain the following information:
To order an OEL/ADE monograph for Hypericin, just click the ADD TO CART button.
If you're wondering about HBEL, we have something for you.
Not the compound you were looking for? You can search the OEL Fastrac catalog to find more available compounds.
Affygility Solutions’s OEL Fastrac service is an user-friendly system that enables us to make confident decisions and focus on moving the compound safely through our facility. We can quickly access the database to determine if a new drug is within the OEL Fastrac library, and if so, immediately download a detailed OEL banding report. The OEL Fastrac system has been a helpful tool in our overall EH&S program.